logo
Select company
Select metric
83.95%Cash to Assets Ratio
VS
Market
97
Sector
90
Industry
85
History
81
$ 1.52Close
$ 0.7 - $ 1.97 52-Week Range
Ticker Information

Ticker

ALLR

Company Name

ALLARITY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALLARITY THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALLR - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 21.2M$ 17.8M83.95%
3/31/2025$ 29.73M$ 27.7M93.19%
12/31/2024$ 22.65M$ 19.53M86.24%
9/30/2024$ 20.38M$ 18.46M90.6%
6/30/2024$ 30.88M$ 19.23M62.28%
3/31/2024$ 11.97M$ 312K2.61%
12/31/2023$ 11.86M$ 166K1.4%
9/30/2023$ 13.88M$ 1.4M10.08%
6/30/2023$ 13.43M$ 420K3.13%
3/31/2023$ 12.7M$ 295K2.32%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ALLARITY THERAPEUTICS INC is calculated as follows: CashnEq [ $ 298K ] / Assets [ $ 33.4M ]
(=) Cash to Assets [ 0.89% ]

ALLR - Cash to Assets Ratio, Last 5 years

0.89%

Minimum

Dec 31, 2020

93.19%

Maximum

Mar 31, 2025

35.67%

Average

21.76%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%